Delivery Order SPE2DB22D1202-SPE2DB23FHXM3
Award Date 8/4/23
Potential Completion Date 8/7/23
Potential Value $17K
Federal Agency
Ultimate Awardee
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $7,302.70 to Amerisourcebergen Drug Corporation to supply 4561971400 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation will deliver 30 units of the specified medication to a facility located in Conshohocken, Pennsylvania between August 28-29, 2023. As a major distributor of pharmaceuticals and medical supplies for the Department of Defense, Amerisourcebergen Drug Corporation supports the DLA's mission to...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at $6,015.40 to Amerisourcebergen Drug Corporation for the supply of 4561961471 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation will deliver 30 units of the specified medication to a location in Conshohocken, Pennsylvania by August 29, 2023 in performance of this order. As a major supplier of pharmaceuticals to the Department of Defense, Amerisourcebergen Drug Corporation and its parent company...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $21,210.61 to Amerisourcebergen Drug Corporation for the supply of 4561357285 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation will deliver 30 units of the specified medication to a location in Conshohocken, Pennsylvania by June 28, 2023 to support the Defense Logistics Agency's medical supply needs. As a leading pharmaceutical wholesaler and distributor, Amerisourcebergen...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $38,226.39 to Amerisourcebergen Drug Corporation for the supply of 4561822369 RINVOQ ER 30 MG tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania over a period from August 15 to August 16, 2023. The Defense Logistics Agency manages the global supply chain for the United...
- The Defense Logistics Agency awarded a delivery order valued at $12,446.64 to AmerisourceBergen Drug Corp for RINVOQ ER 15 mg tablets (30-count units) on September 8, 2025, with completion scheduled for September 9, 2025. This firm fixed-price delivery order represents a non-set-aside competitive award to the pharmaceutical distributor's Corporate Office located in Conshohocken, Pennsylvania. The delivery order falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- The Defense Logistics Agency awarded a firm fixed price delivery order valued at seventy-four thousand six hundred fifty-three dollars and ninety-six cents ($74,653.96) to Amerisourcebergen Drug Corporation for Rinvoq ER 15 mg tablets. The order is for thirty units to be delivered to Amerisourcebergen's facility in Conshohocken, Pennsylvania by June 27, 2023. Amerisourcebergen Corporation is the parent company of Amerisourcebergen Drug Corporation, which will serve as the prime contractor. No...
- The Defense Logistics Agency Troop Support Medical awarded a firm fixed price delivery order valued at $13,912.38 to Amerisourcebergen Drug Corporation for the supply of 4562053873 RINVOQ ER 15 MG tablets. Amerisourcebergen Drug Corporation, a division of Amerisourcebergen Corporation, will deliver 30 units of the specified medication to a location in Conshohocken, Pennsylvania within a one day period of performance between September 5-6, 2023. The Defense Logistics Agency manages the global...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $17,605.35 on August 20, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of August 21, 2025. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order is a child contract...
- The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order contract valued at $6,015.42 to Amerisourcebergen Drug Corp, through its Corporate Office division in Conshohocken, Pennsylvania. The contract is for the supply of RINVOQ ER 15 MG TABLET with a completion date of February 16, 2024. Amerisourcebergen Drug Corp is a for-profit subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The company serves as a...
- The Defense Logistics Agency awarded a $21,799.81 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 1, 2025, for the supply of RINVOQ ER 30 mg tablets in units of 30. This competitively awarded, non-set-aside contract is scheduled for completion by December 2, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA...
- SPE2DB22D1202Indefinite Delivery Contract
- SPE2DB22D1202-SPE2DB23FHXM3Delivery Order
The Defense Logistics Agency awarded a firm fixed price delivery order valued at $17,472.60 to Amerisourcebergen Drug Corporation for the supply of 4561708928 RINVOQ ER 30 MG tablets. Amerisourcebergen Drug Corporation will deliver the pharmaceutical products to a location in Conshohocken, Pennsylvania by August 7, 2023 under the terms of the order. As a major distributor of pharmaceuticals and medical supplies, Amerisourcebergen Drug Corporation will support the DLA's mission to provide materials to the U.S. Department of Defense through this contract. No set aside designation or subcontractors were identified in the award information.
Generated 12/23/23, 2:17 AM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $17.5k | 8/4/23 |